Develops tissue-specific gene therapies that use transient partial cellular reprogramming to treat Alzheimer's and other brain diseases.
Biotech using cellular reprogramming to restore cell health and reverse aspects of aging, injury, and disease.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →